ICD-10-CM Billable Code

M61.141

Myositis ossificans progressiva, right hand

Clinical Classification Guidelines

Medical Intelligence & Overview

Myositis ossificans progressiva (MOP) of the right hand is a rare and complex condition characterized by abnormal bone formation within muscles and soft tissues. Unlike typical bone development, this condition involves the progressive ossification of soft tissues, leading to a loss of mobility and function in the affected hand. MOP primarily affects the muscles surrounding the joints and can cause severe deformities over time, impacting daily activities and quality of life.

Causes & Symptoms

Clinical Causes: Trauma or injury to the hand, which can trigger abnormal bone growth as part of the healing process. Genetic predisposition or inherited conditions that affect tissue growth and ossification. Certain genetic disorders, such as fibrodysplasia ossificans progressiva (FOP), a rare hereditary disease causing widespread soft tissue ossification. Repeated or severe injuries that lead to persistent inflammation and abnormal tissue repair. Some cases have no identifiable cause, and the condition may develop spontaneously.

Key Symptoms: Progressive stiffness and rigidity in the fingers and hand. Formation of palpable,硬硬的硬块 or lumps within the muscles or soft tissues. Limited range of motion, making it difficult to perform everyday tasks. Pain or discomfort, especially with movement or pressure on the affected area. Visible deformities as the abnormal bone growth enlarges and distorts the hand’s shape. Swelling or inflammation may be present during active phases of ossification.

Diagnostic & Treatment

Diagnosis Path: Medical history review focusing on previous trauma or injury to the hand. Physical examination to detect hard masses, deformities, or restricted movement. Imaging studies such as X-rays, which reveal abnormal bone formation within soft tissues. Magnetic Resonance Imaging (MRI) to assess the extent of tissue involvement and differentiate from other soft tissue masses. Biopsy may be performed in uncertain cases to confirm the diagnosis and rule out malignant tumors.

Treatment Protocols: Physical therapy to maintain as much mobility as possible and prevent joint stiffness. Medications such as non-steroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and discomfort. Bisphosphonates might be considered to inhibit abnormal bone growth, though their effectiveness varies. Surgical intervention may be necessary in cases of severe deformity or functional impairment. Surgery is usually delayed until the heterotopic bone has fully matured to reduce recurrence risk. Monitoring disease progression through regular imaging and assessments. Supportive devices or splints to assist with mobility and daily activities.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M61.141 a billable ICD-10 code?
Yes, M61.141 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M61.141?
Clinical documentation must specify the nature of Myositis ossificans progressiva, right hand and any associated comorbidities for accurate reporting.

Cite this Clinical Reference